Fumie Griego was appointed the International Federation of Pharmaceutical Manufacturers & Associations’ (IFPMA) Assistant Director General for Strategic Planning, Policy and Research in early 2017. Griego leads IFPMA’s work on health economics and policy, such as the value of medicines, pricing and reimbursement, and metrics and evaluation. Prior to joining IFPMA, she was Head of Global Oncology Policy and Strategy, Global Government Affairs & Policy at Merck KGaA and Vice President for International Health Policy at Pharmaceutical Research and Manufacturers of America (PhRMA). Before PhRMA, Griego was a senior economist in the White House Office of Management and Budget where she provided U.S. senior officials in both the Bush and Obama Administrations policy advice on a range of health policy issues. Griego holds a PhD in Health Policy from Harvard University and Bachelor and Master of Science degrees in Earth Systems from Stanford University.